10D - investing in a world of infinite possibilities
2
10xBio
2012
10xBio, LLC, a privately-held biotechnology company
3
11.2 Capital
2014
4
1859
2019
Integrated Iterative Intelligent We are accelerating drug discovery to deliver treatments to patients faster. Our powerful engine integrates combinatorial chemistry, pico-scale activity-based screening, and AI, generating millions of empirical datapoints every week to evolve our models.
5
1859, Inc.
1859 Inc. is a platform company combining artificial intelligence and empirical screening data at scale to discover new small molecule medicines for emerging disease targets.
6
1910 Genetics
2018
1910 Genetics is a biotechnology company integrating AI, computation, and biological automation to improve drug development. The company establishes an understanding of the molecular basis of disease to the granularity at which the world understands sickle cell anemia. This understanding drives their integration of artificial intelligence (AI), computation, and biological automation to accelerate the design of small molecule and protein therapeutics.
7
23insights
2017
23insights is specialised in deep learning, evolutionary computing, machine learning, and computer vision.
8
24me
2012
24me - Next Generation Personal Assistant. 24me unites your Calendar and Tasks and uses artificial intelligence to tell you what to do and how to do it.
9
280Bio
28Bio Inc. is building a drug candidate portfolio of innovative precision small molecule inhibitors targeting key pathways for the treatment of cancers with a significant unmet need.
